Cite
APA Citation
, , Kheloufi, F., Poizot-Martin, I., Garraffo, R., Tavenard, A., Quaranta, S., Renault, A., Lavrut, T., Bourlière, M., Halfon, P., Piroth, L., Bellissant, E., Lacarelle, B., Molina, J., & Solas, C. (2017). iTPA Deficiency and Ribavirin Level are Still Predictive of Anaemia in HCV–HIV-Coinfected Patients Receiving Ribavirin Combined with a First-Generation DAA (ANRS HC27 Study). Antiviral therapy, 22(6), 461–469. http://access.bl.uk/ark:/81055/vdc_100128727408.0x000006